Equity futures were mixed following a mixed regular session, as profit-taking and risk aversion appeared to take hold ahead of the forthcoming jobs report. Of note, however, President Trump instructed his “representatives” to purchase $200B of mortgage bonds, sending shares of companies such as Opendoor (OPEN) and Offerpad (OPAD) higher. This marks the second day in a row Trump released commentary on Truth Social that resulted in bullish sentiment for a sector, after his comments on expanding military spending on Wednesday.
Claim 55% Off TipRanks
Trade AXTI with leverageCheck out this evening’s top movers from around Wall Street, compiled by The Fly.
HIGHER AFTER TRUMP INSTRUCTS ‘REPRESENTATIVES’ TO BUY $200B OF MORTGAGE BONDS –
- Offerpad Solutions (OPAD) up 64.5%
- Opendoor Technologies (OPEN) up 12.4%
- Rocket Companies (RKT) up 7%
- UWM Holdings (UWMC) up 5.1%
ALSO HIGHER –
- Jazz Pharmaceuticals (JAZZ) up 5% after naming Thomas Riga chief business officer
- MGM Resorts (MGM) up 0.7% after Texas Capital initiated coverage of the stock with a Buy rating
LOWER AFTER EARNINGS –
ALSO LOWER –
- AXT Inc. (AXTI) down 29% after cutting its Q4 guidance
- Olin (OLN) down 7.8% after updating its Q4 outlook
- General Motors (GM) down 1.6% after saying it expects an additional $6B in charges related to a review of EV capacity and investments
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JAZZ:
- Jazz Pharmaceuticals names Thomas Riga as Chief Business Officer
- Jazz Pharmaceuticals price target raised to $225 from $205 at Morgan Stanley
- Buy Rating on Jazz Pharmaceuticals Driven by Zanidatamab’s Differentiated Efficacy and Clear Regulatory Path in First-Line HER2+ GEA
- BeOne Medicines says HERIZON-GEA-01 met dual primary endpoint of PFS
- Zymeworks touts ‘unprecedented’ results from HERIZON-GEA-01 trial
